Outlook Therapeutics Chief Operations Officer Terry Dagnon's 2022 pay jumps 378% to $1.4M
Outlook Therapeutics reports 2022 executive compensation
By ExecPay News
Published: February 15, 2023
Outlook Therapeutics reported fiscal year 2022 executive compensation information on February 15, 2023.
In 2022, three executives at Outlook Therapeutics received on average a compensation package of $1.4M, a 48% decrease compared to previous year.
Average pay of disclosed executives at Outlook Therapeutics
Terry Dagnon, Chief Operations Officer, received $1.4M in total, which increased by 378% compared to 2021. 67% of Dagnon's compensation, or $967K, was in option awards. Dagnon also received $353K in salary and $114K in other compensation.
Jeff Evanson, Chief Commercial Officer, received a compensation package of $1.4M, which increased by 370% compared to previous year. 69% of the compensation package, or $967K, was in option awards.
C. Russell Trenary III, Chief Executive Officer, earned $1.3M in 2022, a 82% decrease compared to previous year.
Outlook Therapeutics' fiscal year ends on September 30.
Related executives
You may also like
Source: SEC filing on February 15, 2023.